Daniel Busby

Stock Analyst at RBC Capital

(1.17)
# 3,374
Out of 4,789 analysts
6
Total ratings
50%
Success rate
-8.02%
Average return

Stocks Rated by Daniel Busby

Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $16$4
Current: $0.42
Upside: +859.00%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43$44
Current: $24.56
Upside: +79.19%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $4.93
Upside: +1.52%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $206.15
Upside: -34.51%